Huanyu Jin

1.0k total citations
9 papers, 861 citations indexed

About

Huanyu Jin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Huanyu Jin has authored 9 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Huanyu Jin's work include Tea Polyphenols and Effects (3 papers), Tannin, Tannase and Anticancer Activities (2 papers) and Immune cells in cancer (2 papers). Huanyu Jin is often cited by papers focused on Tea Polyphenols and Effects (3 papers), Tannin, Tannase and Anticancer Activities (2 papers) and Immune cells in cancer (2 papers). Huanyu Jin collaborates with scholars based in United States and China. Huanyu Jin's co-authors include Chung S. Yang, Zhihong Yang, Hang Xiao, Fei Guan, Hong Wang, Gang Lü, Chi‐Tang Ho, Trusha Patel, Shiming Li and Gary Lu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Huanyu Jin

9 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanyu Jin United States 8 306 286 275 129 112 9 861
Rajesh Agarwal United States 10 446 1.5× 284 1.0× 338 1.2× 88 0.7× 94 0.8× 11 1.0k
Jian Xie United States 8 303 1.0× 196 0.7× 211 0.8× 103 0.8× 41 0.4× 14 723
Daisuke Umeda Japan 13 346 1.1× 232 0.8× 204 0.7× 78 0.6× 30 0.3× 20 773
Chung Ho Ryu South Korea 20 112 0.4× 536 1.9× 217 0.8× 112 0.9× 191 1.7× 32 1.0k
Li-Shu Wang United States 20 91 0.3× 540 1.9× 424 1.5× 83 0.6× 140 1.3× 25 1.1k
Prosenjit Saha India 20 124 0.4× 337 1.2× 100 0.4× 122 0.9× 139 1.2× 46 789
Xiaoli Peng China 16 155 0.5× 540 1.9× 241 0.9× 108 0.8× 86 0.8× 26 1.1k
Govindaraj Sharmila India 15 92 0.3× 508 1.8× 131 0.5× 142 1.1× 163 1.5× 23 964
Ramamurthi Vidya Priyadarsini India 14 83 0.3× 682 2.4× 198 0.7× 118 0.9× 250 2.2× 20 1.2k

Countries citing papers authored by Huanyu Jin

Since Specialization
Citations

This map shows the geographic impact of Huanyu Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanyu Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanyu Jin more than expected).

Fields of papers citing papers by Huanyu Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanyu Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanyu Jin. The network helps show where Huanyu Jin may publish in the future.

Co-authorship network of co-authors of Huanyu Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Huanyu Jin. A scholar is included among the top collaborators of Huanyu Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanyu Jin. Huanyu Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jin, Huanyu, Xin Cheng, Nga Thi Thuy Nguyen, et al.. (2017). Abstract 815: Using CRISPR/Cas9 to generate isogenic cell lines and reference standards for applications in cancer diagnostics. Cancer Research. 77(13_Supplement). 815–815. 1 indexed citations
2.
Jin, Huanyu, Hong Wang, Gary Lu, et al.. (2014). NNK-Induced DNA Methyltransferase 1 in Lung Tumorigenesis in A/J Mice and Inhibitory Effects of (−)-Epigallocatechin-3-Gallate. Nutrition and Cancer. 67(1). 167–176. 32 indexed citations
3.
Zhu, Li, Xiaojiao Cheng, Jindong Shi, et al.. (2013). Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. Cancer Letters. 343(1). 80–89. 32 indexed citations
4.
Tu, Shui Ping, Huanyu Jin, Shi Jin, et al.. (2011). Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth. Cancer Prevention Research. 5(2). 205–215. 139 indexed citations
5.
Yang, Chung S., et al.. (2011). Cancer prevention by tea: Evidence from laboratory studies. Pharmacological Research. 64(2). 113–122. 201 indexed citations
7.
Yang, Zhihong, et al.. (2009). Synergistic actions of atorvastatin with γ‐tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. International Journal of Cancer. 126(4). 852–863. 69 indexed citations
8.
Xiao, Hang, Chung S. Yang, Shiming Li, et al.. (2008). Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel Inhibit growth of human lung cancer cells by apoptosis. Molecular Nutrition & Food Research. 53(3). 398–406. 137 indexed citations
9.
Lü, Gang, Hang Xiao, Hui You, et al.. (2008). Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin. Clinical Cancer Research. 14(15). 4981–4988. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026